drugset / Trial / NCT00786370

Dexmedetomidine vs. Propofol for Cataract Surgery

NCT00786370 ↗

Phase 4 Completed 24 enrolled The Cooper Health System
RandomizedParallel-groupSingle-blindTreatment

Summary

The use of dexmedetomidine in cataract surgery is still limited and to date only one study has examined anesthetic technique in this patient population. This pilot study will therefore compare the use of dexmedetomidine and propofol in subjects undergoing cataract surgery. The primary endpoint will be based on simple cardiorespiratory measures often associated with complications from sedation as well as assessment of the achieved sedation by the attending anesthesiologist and surgeon.

Timeline

Start
2008-04
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg —
Subject Dexmedetomidine Other / unclassified 0.7 ug/kg —
Comparator Propofol Small molecule 50 ug/kg —
Comparator Propofol Small molecule 100 ug/kg —

Indications